Duchenne muscular dystrophy - DMD

Duchenne muscular dystrophy (DMD) is a severely debilitating childhood neuromuscular disease that affects 1 in 3,500 live male births. This rare disease is caused by mutations in the dystrophin gene...

Cardiac Catheterization

Cardiac tamponade

Cardiac response

Cardiac output

Add-on pantoprazole may boost glycemic control in diabetics

NEW YORK (Reuters Health) - The proton pump inhibitor (PPI) pantoprazole seemed to help type 2 diabetics on oral therapy in a small study from India.

More white blood cells in cardiac patients with depression

(Medical Xpress)—Cardiac patients suffering from depression are at greater risk for new cardiac events or cardiac death than patients without depression. It is still unclear which underlying mechani...

Human medicines European Public Assessment Report (EPAR): Controloc Control, pantoprazole, Revision: 3, Authorised

Human medicines European Public Assessment Report (EPAR): Pantoloc Control, pantoprazole, Revision: 5, Authorised

Human medicines European Public Assessment Report (EPAR): Pantecta Control, pantoprazole, Revision: 3, Authorised

Human medicines European Public Assessment Report (EPAR): Somac Control, pantoprazole, Revision: 4, Authorised

Human medicines European Public Assessment Report (EPAR): Pantozol Control, pantoprazole, Revision: 3, Authorised

Sevoflurane anesthesia does not reduce myocardial ischemia in non-cardiac surgery

NEW YORK (Reuters Health) - A randomized controlled trial comparing the volatile anesthetic sevoflurane to IV propofol in cardiac patients having major non-cardiac surgery showed no difference in...

A Multicenter, Randomized, Open-Label, Pharmacokinetics and Safety Study of Pantoprazole Tablets in Children and Adolescents Aged 6 Through 16 Years With Gastroesophageal Reflux Disease.

Children with gastroesophageal reflux disease (GERD) may benefit from gastric acid suppression with proton pump inhibitors such as pantoprazole. Effective treatment with pantoprazole requires correct...

Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction.

1 The effect of pantoprazole on vecuronium-induced neuromuscular blockade in in vivo has not been clearly defined. In this study, we demonstrate that chronic administration, but not acute administra...

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study.

Background: Until now there has been no study that directly compares the effect of lansoprazole and pantoprazole administered intravenously on intragastric acidity. The aim of this study is to compare...

Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil.

Objectives. MMF is cleaved in the acidic milieu of the gastric compartment. However, its absorption might be impeded by proton pump inhibitors (PPIs), which suppress acid production and thus increase...

A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities.

Objective of the study The purpose of this prospective intervention study was to assess the number of patients with Y-site incompatibilities before and after implementation of quality improvement meas...